Paris, France

Yu-Chun Lone

USPTO Granted Patents = 3 


Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 2000-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yu-Chun Lone: Innovator in Transgenic Research

Introduction

Yu-Chun Lone is a prominent inventor based in Paris, France. He has made significant contributions to the field of transgenic research, particularly in the development of transgenic mice with human major histocompatibility complex (MHC) phenotypes. His work has implications for experimental uses and applications in biomedical research.

Latest Patents

Yu-Chun Lone holds three patents, with his latest inventions focusing on transgenic mice. These mice are engineered to have disrupted H2 class I and class II genes, along with functional HLA class I and class II transgenes. The transgenic mice are deficient in both H2 class I and class II molecules, which allows for the study of human immune responses in a controlled environment. The genotype of these mice includes HLA-A2HLA-DR1β2m°IAβ°. His inventions also encompass methods for utilizing these transgenic mice in various experimental applications.

Career Highlights

Throughout his career, Yu-Chun Lone has worked with esteemed institutions such as the Institut Pasteur and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing our understanding of immunology and genetic engineering.

Collaborations

Yu-Chun Lone has collaborated with notable colleagues, including Anthony Pajot and Claude Auriault. These partnerships have further enriched his research endeavors and contributed to the success of his projects.

Conclusion

Yu-Chun Lone is a distinguished inventor whose work in transgenic research has opened new avenues for scientific exploration. His innovative patents and collaborations reflect his commitment to advancing the field of biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…